Bishop JF, Matthews JP, McGrath K, Yuen K, Wolf MM, Szer J. Factors influencing 20-hour increments after platelet transfusion. Transfusion 1991; 31:392-6.10.1046/j.1537-2995.1991.31591263191.x2048176Search in Google Scholar
Shibata Y, Juji T, Nishizawa Y, Sakamoto H, Ozawa N. Detection of platelet antibodies by a newly developed mixed agglutination with platelets. Vox Sang 1981;41:25-31.10.1111/j.1423-0410.1981.tb01007.x7324440Search in Google Scholar
Terasaki PI,Bernoco D, Park MS, Ozturk G, Imaki Y. Microdroplet testing for HLA-A, -B, -C and -D antigens. Am J Clin Pathol 1978;69:103-7.10.1093/ajcp/69.2.10375690Search in Google Scholar
Legler TJ, Fischer I, Dittman J,et al. Frequency and causes of refractoriness in multiply transfused patients. Ann Hematol 1997;74:185-9.10.1007/s0027700502809174547Search in Google Scholar
Sanz C, Freire C, Alcorta I, Ordinas A, Pereira A. Platelet-specific antibodies in HLA-immunized patients receiving chronic platelet support. Transfusion 2001;41:762-5.10.1046/j.1537-2995.2001.41060762.x11399816Search in Google Scholar
McFarland JG, Larson EB, Hillman RS, Slichter SJ. Cost-benefit analysis of a plateletapheresis program.Transfusion 1986;26:91-7.10.1046/j.1537-2995.1986.26186124042.x3080832Search in Google Scholar
The Trial to Reduce Alloimmunization to Platelets Study Group: Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. N Engl J Med 1997;337:1861-9.10.1056/NEJM1997122533726019417523Search in Google Scholar
Moroff G, Garratty G, Heal JM,et al. Selection of platelets for refractory patients by HLA matching and prospective crossmatching. Transfusion 1992; 32:633-40.10.1046/j.1537-2995.1992.32792391036.x1519326Search in Google Scholar
Petz LD, Garratty G, Calhoun L, et al. Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity. Transfusion 2000;40:1446-56.10.1046/j.1537-2995.2000.40121446.x11134563Search in Google Scholar
